Works about THIOTEPA

Results: 70
    1
    2
    3

    KAPOSI'S SARCOMA.

    Published in:
    1964
    By:
    • Biggs, B.;
    • Cooke, R. A.;
    • McGovern, V. J.
    Publication type:
    Case Study
    4

    Chemotherapy-induced Toxic Leukoencephalopathy.

    Published in:
    Turkish Journal of Neurology / Turk Noroloji Dergisi, 2020, v. 26, n. 1, p. 49, doi. 10.4274/tnd.2019.12369
    By:
    • Yetkin, Mehmet Fatih;
    • Göl, Mehmet Fatih;
    • Köse, Elif Gülşen;
    • Kaynar, Leylagül
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin.

    Published in:
    Leukemia & Lymphoma, 2013, v. 54, n. 8, p. 1713, doi. 10.3109/10428194.2012.753444
    By:
    • Larsen, Jeremy T.;
    • Hogan, William J.;
    • Micallef, Ivana N.;
    • Dispenzieri, Angela;
    • Gertz, Morie A.;
    • Inwards, David J.;
    • Tun, Han W.;
    • Roy, Vivek;
    • Geyer, Susan M.;
    • Allred, Jacob B.;
    • Wu, Wenting;
    • Ansell, Stephen M.;
    • Elliott, Michelle A.;
    • Tefferi, Ayalew;
    • Porrata, Luis F.;
    • Gastineau, Dennis A.;
    • Lacy, Martha Q.;
    • Litzow, Mark R.
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT.

    Published in:
    Bone Marrow Transplantation, 2010, v. 45, n. 9, p. 1408, doi. 10.1038/bmt.2009.371
    By:
    • Perales, M-A;
    • Jenq, R;
    • Goldberg, J D;
    • Wilton, A S;
    • Lee, S S E;
    • Castro-Malaspina, H R;
    • Hsu, K;
    • Papadopoulos, E B;
    • van den Brink, M R M;
    • Boulad, F;
    • Kernan, N A;
    • Small, T N;
    • Wolden, S;
    • Collins, N H;
    • Chiu, M;
    • Heller, G;
    • O'Reilly, R J;
    • Kewalramani, T;
    • Young, J W;
    • Jakubowski, A A
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    When an HLA identical donor is not available in adults with hematological neoplasms: single-center comparison of single-unit cord blood transplantation and haploidentical-related PBSC transplantation with PTCy using a standardized conditioning platform (thiotepa-busulfan-fludarabine).

    Published in:
    2020
    By:
    • Esquirol, Albert;
    • Querol, Sergi;
    • Garcia-Cadenas, Irene;
    • Novelli, Silvana;
    • Garrido, Ana;
    • Saavedra, Silvana;
    • Moreno, Carol;
    • Granell, Miquel;
    • Caballero, Ana;
    • Brunet, Salut;
    • Briones, Javier;
    • Martino, Rodrigo;
    • Sierra, Jorge
    Publication type:
    journal article
    37
    38

    Umbilical cord blood transplantation in adults with advanced hodgkin's disease: high incidence of post-transplant lymphoproliferative disease.

    Published in:
    European Journal of Haematology, 2016, v. 96, n. 2, p. 128, doi. 10.1111/ejh.12557
    By:
    • Piñana, José Luis;
    • Sanz, Jaime;
    • Esquirol, Albert;
    • Martino, Rodrigo;
    • Picardi, Alessandra;
    • Barba, Pere;
    • Parody, Rocio;
    • Gayoso, Jorge;
    • Montesinos, Pau;
    • Guidi, Stefano;
    • Terol, Maria José;
    • Moscardó, Federico;
    • Solano, Carlos;
    • Arcese, William;
    • Sanz, Miguel A.;
    • Sierra, Jorge;
    • Sanz, Guillermo
    Publication type:
    Article
    39

    Thiotepa-based versus total body irradiation-based myeloablative conditioning prior to allogeneic stem cell transplantation for acute myeloid leukaemia in first complete remission: a retrospective analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

    Published in:
    European Journal of Haematology, 2016, v. 96, n. 1, p. 90, doi. 10.1111/ejh.12553
    By:
    • Eder, Sandra;
    • Labopin, Myriam;
    • Arcese, William;
    • Or, Reuven;
    • Majolino, Ignazio;
    • Bacigalupo, Andrea;
    • Rosa, Gennaro;
    • Volin, Liisa;
    • Beelen, Dietrich;
    • Veelken, Hendrik;
    • Schaap, Nicolaas P. M.;
    • Kuball, Jurgen;
    • Cornelissen, Jan;
    • Nagler, Arnon;
    • Mohty, Mohamad
    Publication type:
    Article
    40
    41
    42
    43

    Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma.

    Published in:
    Cancer (0008543X), 2015, v. 121, n. 2, p. 226, doi. 10.1002/cncr.29023
    By:
    • Chen, Yi‐Bin;
    • Batchelor, Tracy;
    • Li, Shuli;
    • Hochberg, Ephraim;
    • Brezina, Mark;
    • Jones, Sooae;
    • Del Rio, Candice;
    • Curtis, Morgan;
    • Ballen, Karen K.;
    • Barnes, Jeffrey;
    • Chi, Andrew S.;
    • Dietrich, Jorg;
    • Driscoll, Jessica;
    • Gertsner, Elizabeth R.;
    • Hochberg, Fred;
    • LaCasce, Ann S.;
    • McAfee, Steven L.;
    • Spitzer, Thomas R.;
    • Nayak, Lakshmi;
    • Armand, Philippe
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50